RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
-12.67%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$1.68B
AUM Growth
+$1.68B
(-10%)
Cap. Flow
+$138M
Cap. Flow
% of AUM
8.2%
Top 10 Holdings %
Top 10 Hldgs %
55%
Holding
67
New
15
Increased
26
Reduced
11
Closed
7
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$55.3M |
| 2 |
BLU
BELLUS Health Inc.
BLU
|
$26.9M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$26.3M |
| 4 |
Insulet
PODD
|
$18.3M |
| 5 |
PTC Therapeutics
PTCT
|
$17.4M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$34.6M |
| 2 |
Illumina
ILMN
|
$30.2M |
| 3 |
Arrowhead Research
ARWR
|
$29.7M |
| 4 |
OrthoPediatrics
KIDS
|
$14.7M |
| 5 |
Myriad Genetics
MYGN
|
$10.5M |
Sector Composition
| 1 | Healthcare | 94.09% |
| 2 | Communication Services | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rocket Pharmaceuticals
RCKT
$354M
| $193M | 11.45% | 16,587,491 | – | – |
|
|
2
Alnylam Pharmaceuticals
ALNY
$58.5B
| $142M | 8.45% | 1,767,628 -430,466 | -20% | -$34.6M |
|
|
3
PTC Therapeutics
PTCT
$3.92B
| $123M | 7.34% | 3,651,361 +514,000 | +16% | +$17.4M |
|
|
DRNA
4
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $89.1M | 5.3% | 6,202,425 +50,322 | +0.8% | +$723K |
|
5
Bristol-Myers Squibb
BMY
$96B
| $79.4M | 4.72% | 1,565,307 +3,389 | +0.2% | +$172K |
|
6
Stoke Therapeutics
STOK
$1.08B
| $69.4M | 4.13% | 3,355,466 | – | – |
|
7
Milestone Pharmaceuticals
MIST
$156M
| $63.8M | 3.8% | 3,521,856 | – | – |
|
|
8
Zimmer Biomet
ZBH
$21B
| $55.3M | 3.29% | +403,000 | New | +$55.3M |
|
9
Masimo
MASI
$7.59B
| $55.2M | 3.28% | 371,155 -1,103 | -0.3% | -$164K |
|
10
Sarepta Therapeutics
SRPT
$1.78B
| $54.6M | 3.24% | 724,311 +120,075 | +20% | +$9.04M |
|
|
ACHN
11
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $49.9M | 2.97% | 13,864,383 | – | – |
|
|
MRTX
12
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $46.2M | 2.75% | 592,776 +337,506 | +132% | +$26.3M |
|
13
Q32 Bio
QTTB
$20.9M
| $44.3M | 2.64% | 2,449,478 +394,546 | +19% | +$7.14M |
|
|
AXNX
14
DELISTED
Axonics, Inc. Common Stock
AXNX
| $41.3M | 2.46% | 1,534,605 | – | – |
|
15
Vericel Corp
VCEL
$1.83B
| $40.1M | 2.38% | 2,645,476 +38,705 | +1% | +$586K |
|
16
Establishment Labs
ESTA
$1.2B
| $38.6M | 2.29% | 2,039,681 +156,501 | +8% | +$2.96M |
|
|
MYOK
17
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $37.8M | 2.25% | 725,025 +1,570 | +0.2% | +$81.9K |
|
18
Adverum Biotechnologies
ADVM
$64.6M
| $34.2M | 2.04% | 6,281,003 -39,347 | -0.6% | -$214K |
|
|
TBIO
19
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $31.2M | 1.86% | 3,148,628 +709,378 | +29% | +$7.03M |
|
|
BLU
20
DELISTED
BELLUS Health Inc.
BLU
| $26.9M | 1.6% | +4,178,156 | New | +$26.9M |
|
|
AGEN
21
Agenus
AGEN
$133M
| $23.8M | 1.41% | 9,213,191 -871,023 | -9% | -$2.25M |
|
22
Apyx Medical
APYX
$75.3M
| $22.8M | 1.36% | 3,370,279 -29,620 | -0.9% | -$201K |
|
23
ProQR Therapeutics
PRQR
$237M
| $21.3M | 1.27% | 3,700,833 -22,117 | -0.6% | -$127K |
|
|
24
Insulet
PODD
$23.9B
| $18.3M | 1.09% | +111,232 | New | +$18.3M |
|
|
LJPC
25
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $17.7M | 1.06% | 2,016,269 +4,929 | +0.2% | +$43.4K |
|